Filing Details

Accession Number:
0001104659-12-047933
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-06 17:29:31
Reporting Period:
2012-07-03
Filing Date:
2012-07-06
Accepted Time:
2012-07-06 17:29:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1491576 Tesaro Inc. TSRO Pharmaceutical Preparations (2834) 272249687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184592 C Beth Seidenberg C/O Tesaro, Inc.
1000 Winter Street, Suite 3300
Waltham MA 02451
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-03 1,816,748 $0.00 1,816,748 No 4 C Indirect See footnote
Common Stock Acquisiton 2012-07-03 153,695 $0.00 153,695 No 4 C Indirect See footnote
Common Stock Acquisiton 2012-07-03 204,889 $13.50 2,021,637 No 4 P Indirect See footnote
Common Stock Acquisiton 2012-07-03 17,333 $13.50 171,028 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2012-07-03 6,358,619 $0.00 1,816,748 $0.00
Common Stock Series B Preferred Stock Disposition 2012-07-03 537,932 $0.00 153,695 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series B Preferred Stock converted into shares of TESARO, Inc. common stock on a 3.5 for 1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
  2. Reflects a 1-for-3.5 reverse stock split which became effective prior to the closing of the Issuer's initial public offering.
  3. The shares are held directly by Kleiner Perkins Caufield & Byers XIV, LLC ("KPCB XIV"). The managing member of KPCB XIV is KPCB XIV Associates, LLC ("KPCB XIV Associates"), of which the Reporting Person is a member. The voting and dispositive control over the shares is shares by the members of KPCB XIV Associates. The shares are held for convenience in the name of "KPCB Holdings, Inc. as nominee."
  4. The Reporting Person disclaims beneficial ownership over all Issuer shares held for convenience in the name of "KPCB Holdings, Inc. as nominee," except to the extent of her pecuniary interest therein and this filing is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.
  5. The shares are held directly by KPCB XIV Founders Fund, LLC ("KPCB XIV Founders"). The managing member of KPCB XIV Founders is KPCB XIV Associates, LLC ("KPCB XIV Associates"), of which the Reporting Person is a member. The voting and dispositive control over the shares is shares by the members of KPCB XIV Associates. The shares are held for convenience in the name of "KPCB Holdings, Inc. as nominee."